Lee G.: Can We Transform Dengue Patient Management with Better Coagulation Assessment?
Lee G., Sales and Marketing Manager at AMD Solutions Sdn Bhd, shareda post on LinkedIn:
“Can we transform dengue patient management with better coagulation assessment?
Every year, dengue affects millions of people worldwide, yet clinicians still face critical questions:
- Which patients are truly at high risk of bleeding?
- Can severe coagulopathy be detected before clinical deterioration?
- Are platelet counts alone sufficient to guide transfusion decisions, or are we missing part of the picture?
Viscoelastic testing, such as thromboelastography (TEG), has shown promise in evaluating clot formation, clot strength, and fibrinolysis in various clinical settings. However, its role in dengue management remains underexplored and deserves further investigation.
I am exploring the potential collaboration in clinical study to evaluate TEG alongside conventional coagulation biomarkers in hospitalized dengue patients. Our goal is to generate evidence that could improve early risk stratification, optimize blood component utilization, and ultimately enhance patient care.
I would welcome collaboration with:
- Hematologists
- Infectious disease physicians
- Emergency physicians
- Intensivists
- Pathologists
- Clinical laboratory scientists
- Universities and research institutions
- Hospitals interested in multicentre clinical research
If you share an interest in advancing evidence-based dengue care, I’d be delighted to connect and explore potential collaboration opportunities.
Together, we can generate the evidence needed to improve patient outcomes.”
Stay updated with Hemostasis Today.
-
Aug 16, 2026, 12:03Fawaz AlOtaibi: Can AI Replace Contrast CTA for Vascular Screening?
-
Aug 16, 2026, 10:31Erhabor Osaro: Critical Issues to Consider During the Clinical Blood Transfusion Process
-
Aug 16, 2026, 10:14Juan Manuel Cisneros Carrasco: The Architects Behind the Blood Donation System
-
Aug 16, 2026, 10:06Honoring the Life and Legacy of Dr. Reed Pyeritz – GADA Canada
-
Aug 16, 2026, 09:51Javier Amador-Castañeda: When a 32 Percent Reduction Tells Only Part of the Story
-
Aug 16, 2026, 09:33Anıl Güneş: The Unseen Threat – How Global Climate Change Impacts Cardiovascular Health
-
Aug 16, 2026, 09:09Robert John Nesbitt: Can We Prevent Stroke Without Increasing Bleeding Risk
-
Aug 16, 2026, 06:19Dennis Wolf: Is ZEUS the End of Anti-Inflammatory Therapy in Atherosclerosis?
-
Aug 16, 2026, 06:05Nicolas Hubacz: A New Target for Stroke Recovery